Palo Verde Cancer Specialists ( Site 0052) — Glendale, Arizona

Palo Verde Cancer Specialists ( Site 0052) is a clinical research site located in Glendale, Arizona, United States 85304.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Palo Verde Cancer Specialists ( Site 0052) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Essential Thrombocythemia.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Palo Verde Cancer Specialists ( Site 0052)?

Palo Verde Cancer Specialists ( Site 0052) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Palo Verde Cancer Specialists ( Site 0052) conducted?

Palo Verde Cancer Specialists ( Site 0052) has 1 clinical trials on record, with 1 currently active. Their work covers Essential Thrombocythemia.

Is Palo Verde Cancer Specialists ( Site 0052) accredited by Crixeo Health?

Palo Verde Cancer Specialists ( Site 0052) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Palo Verde Cancer Specialists ( Site 0052)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.